Cammarata, R.; Catamerò, A.; La Vaccara, V.; Coppola, R.; Caputo, D.
Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. Cancers 2025, 17, 3085.
https://doi.org/10.3390/cancers17183085
AMA Style
Cammarata R, Catamerò A, La Vaccara V, Coppola R, Caputo D.
Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. Cancers. 2025; 17(18):3085.
https://doi.org/10.3390/cancers17183085
Chicago/Turabian Style
Cammarata, Roberto, Alberto Catamerò, Vincenzo La Vaccara, Roberto Coppola, and Damiano Caputo.
2025. "Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence" Cancers 17, no. 18: 3085.
https://doi.org/10.3390/cancers17183085
APA Style
Cammarata, R., Catamerò, A., La Vaccara, V., Coppola, R., & Caputo, D.
(2025). Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. Cancers, 17(18), 3085.
https://doi.org/10.3390/cancers17183085